Sperm Morphology

Fertility marker

Sperm Morphology

Category: Fertility
Unit: % Normal Forms

Percentage of sperm with normal shape and structure (strict Kruger criteria). WHO lower reference limit is 4%.

PED Notes

Morphology reflects the quality of spermatogenesis. AAS-disrupted hormonal milieu produces abnormal sperm forms (teratozoospermia). Even naturally, only a small percentage of sperm are morphologically normal — the 4% threshold is already low. During AAS use, morphology typically drops below this threshold. Recovery of normal morphology post-PCT can take 3+ months after concentration recovers, as it reflects a full spermatogenic cycle (~74 days). Persistently abnormal morphology after prolonged recovery may warrant fertility specialist referral.

On-cycle context: Abnormal morphology on AAS is expected due to disrupted spermatogenesis. If you are not planning to conceive, this is not alarming — morphology is the last parameter to normalise post-PCT (allow 5-6 months after concentration recovers).

See Semen Volume marker for full PCT and fertility recovery protocol.

Morphology-specific notes:

  • Morphology reflects spermatogenesis quality over the past ~74 days (one full sperm development cycle)
  • Antioxidant stack is the primary intervention for improving morphology:
    • Vitamin C -- 1000mg/day
    • Vitamin E -- 400 IU/day
    • Selenium -- 200mcg/day
    • Zinc -- 30mg/day
    • CoQ10 -- 200-400mg/day
    • Folate -- 800mcg/day (supports DNA integrity during spermatogenesis)
  • Avoid environmental toxins: BPA (plastic containers), pesticides, heavy metals
  • Morphology is the last parameter to normalise post-AAS -- allow at least 2-3 full spermatogenic cycles (5-6 months) after concentration recovers
  • If morphology remains <4% after 12+ months of recovery with optimised hormones and supplements, ICSI (intracytoplasmic sperm injection) can bypass morphology issues for fertility

References:

  • McBride, J. A., & Coward, R. M. (2016). Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian Journal of Andrology, 18(3), 373-380. DOI: 10.4103/1008-682X.173938
  • Zhao, J., Dong, X., Hu, X., et al. (2016). Zinc levels in seminal plasma and their correlation with male infertility. Scientific Reports, 6, 22386. DOI: 10.1038/srep22386
  • Rayman, M. P. (2012). Selenium and human health. The Lancet, 379(9822), 1256-1268. DOI: 10.1016/S0140-6736(11)61452-9
  • Garrido-Maraver, J., Cordero, M. D., Oropesa-Avila, M., et al. (2014). Coenzyme Q10 therapy. Molecular Syndromology, 5(3-4), 187-197. DOI: 10.1159/000360101

History Chart

Reading History

Frequently Asked Questions

Reference Ranges

Standard Range

4 - 100 % Normal Forms

VitalMetrics Range

5 - 100 % Normal Forms

Statistics